The U.S. government agency Medical Supply Chain awarded a firm fixed price delivery order contract worth $229,284.00 to Glaxosmithkline, LLC, a pharmaceutical company, for the provision of zanamivir, an antiviral medication, with a period of performance ending on December 14, 2016. This contract was not set aside for any specific business type. Glaxosmithkline has previously been awarded other federal contracts and grants for the supply of various pharmaceutical products and services, including influenza vaccines, COVID-19 treatments, and vaccine storage and rotation. The company has also served as a subcontractor on a Department of Defense contract for COVID-19 monoclonal antibody therapeutics distribution and logistics.